Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with γ-irradiation-Reference-Cited by-同舟云学术

Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with γ-irradiation

Published:2000-11 Issue:1 Volume:160 Page:107-113
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Papazisis Konstantinos T.,Zambouli Dimitra,Kimoundri Ourania T.,Papadakis Emmanuel S.,Vala Vasiliki,Geromichalos George D.,Voyatzi Soultana,Markala Dimitra,Destouni Evangelia,Boutis Lazaros,Kortsaris Alexander H.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Cell cycle regulation in irradiated and non-irradiated cells;Iliakis;Semin. Oncol.,1997

2. Cell cycle checkpoints: prevent an identity crisis;Elledge;Science,1996

3. Cell-cycle arrest versus cell death in cancer therapy;Waldman;Nat. Med.,1997

4. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53;Wang;J. Natl. Cancer Inst.,1996

5. Regulation of the Fas apoptotic cell death pathway by Abl;McGahon;J. Biol. Chem.,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Cancer Effects of Soy Isoflavones against Cancer by Radiosensitizing Properties: A Systematic Review;Current Cancer Therapy Reviews;2024-06-21

2. A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing;Nano Letters;2024-04-29

3. The Oncogenic Protein, Breakpoint Cluster (BCR)-Abelson Kinase (ABL) and Chronic Myelocytic Leukemia (CML): Insight Into the Drug Resistance Mechanisms and Approaches for Targeting BCR-ABL in CML;Reference Module in Biomedical Sciences;2021

4. Therapeutic Potential of (−)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma Models;Marine Drugs;2020-09-29

5. Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance;European Journal of Medicinal Chemistry;2020-05